Uliledlimab Uses, Dosage, Side Effects and more
Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).
| Attribute | Details |
|---|---|
| Trade Name | Uliledlimab |
| Generic | Uliledlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
